Phenotype
|
Fish
|
Conditions
|
Figures
|
Kupffer's vesicle cilium decreased amount, abnormal
|
AB/TU + MO1-inpp5e
|
standard conditions
|
Fig. 4
from Luo et al., 2012
|
melanosome transport increased duration, abnormal
|
AB/TU + MO1-inpp5e
|
standard conditions
|
Fig. 6
from Luo et al., 2012
|
Kupffer's vesicle cilium decreased length, abnormal
|
AB/TU + MO1-inpp5e
|
standard conditions
|
Fig. 4
from Luo et al., 2012
|
pronephric duct cilium decreased length, abnormal
|
AB/TU + MO1-inpp5e
|
standard conditions
|
Fig. 5
from Luo et al., 2012
|
post-vent region kinked, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
pronephros cystic, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
whole organism anatomical axis asymmetrical, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
retina development in camera-type eye disrupted, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
pericardium edematous, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
eye decreased size, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
whole organism decreased pigmentation, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
retina disorganized, abnormal
|
AB/TU + MO1-inpp5e + MO4-tp53
|
standard conditions
|
Fig. 2
from Luo et al., 2012
|
pronephric tubule cilium decreased amount, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. S7
from Xu et al., 2018
|
pronephric duct 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate mislocalised, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
pronephric duct cilium assembly occurrence, ameliorated
|
TU + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct has number of pronephric duct motile cilium, ameliorated
|
TU + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric glomerulus morphology, ameliorated
|
TU + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephros morphogenesis process quality, ameliorated
|
TU + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct cilium assembly decreased occurrence, abnormal
|
TU + MO1-inpp5e
|
control
|
Fig. 1,
Fig. 4
from Xu et al., 2017
|
pronephros morphogenesis decreased process quality, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1,
Fig. 4
from Xu et al., 2017
|
pronephros renal filtration rate, ameliorated
|
TU + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct filamentous actin mislocalised, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
pronephric duct 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate mislocalised, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
pronephric tubule ciliary basal body mislocalised, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. S5
from Xu et al., 2018
|
multi-ciliated epithelial cell malformed, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. S7
from Xu et al., 2018
|
pronephric duct establishment of epithelial cell apical/basal polarity decreased process quality, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
pronephric glomerulus cystic, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 3,
Fig. 4
from Xu et al., 2017
|
pronephric duct ciliary basal body-plasma membrane docking decreased process quality, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
pronephros renal filtration decreased rate, abnormal
|
TU + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|
pronephric duct ciliary basal body mislocalised, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
pronephric duct has fewer parts of type pronephric duct motile cilium, abnormal
|
TU + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|
pronephric duct apical plasma membrane ab1-atp1a1 labeling mislocalised, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
pronephric duct apical plasma membrane ezrb expression absent, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 3
from Xu et al., 2017
|
pronephric duct actin filament bundle distribution decreased process quality, abnormal
|
TU + MO1-inpp5e
|
standard conditions
|
Fig. 1
from Xu et al., 2017
|
kidney cystic, exacerbated
|
TU + MO1-inpp5e + MO1-pip5k1aa
|
standard conditions
|
Fig. S6
from Xu et al., 2018
|
kidney cystic, exacerbated
|
TU + MO1-inpp5e + MO1-pip5k1ca
|
standard conditions
|
Fig. S6
from Xu et al., 2018
|
pronephric glomerulus cystic, exacerbated
|
TU + MO1-inpp5e + MO2-ezrb
|
standard conditions
|
Fig. 3
from Xu et al., 2017
|
kidney cystic, exacerbated
|
TU + MO1-inpp5e + MO2-pip5k1ab
|
standard conditions
|
Fig. S6
from Xu et al., 2018
|
pronephric duct establishment of epithelial cell apical/basal polarity process quality, ameliorated
|
tju9Tg + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate mislocalised, abnormal
|
tju9Tg + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|
pronephric duct establishment of epithelial cell apical/basal polarity decreased process quality, abnormal
|
tju9Tg + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|
pronephric duct apical plasma membrane EGFP expression decreased amount, abnormal
|
tju9Tg + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|
pronephric duct apical plasma membrane EGFP expression amount, ameliorated
|
tju9Tg + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate position, ameliorated
|
tju9Tg + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate mislocalised, abnormal
|
tju10Tg + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|
pronephric duct 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate position, ameliorated
|
tju10Tg + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct establishment of epithelial cell apical/basal polarity process quality, ameliorated
|
tju10Tg + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct apical plasma membrane EGFP expression position, ameliorated
|
tju10Tg + MO1-inpp5e
|
chemical treatment by environment: LY294002
|
Fig. 4
from Xu et al., 2017
|
pronephric duct apical plasma membrane EGFP expression mislocalised, abnormal
|
tju10Tg + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|
pronephric duct establishment of epithelial cell apical/basal polarity decreased process quality, abnormal
|
tju10Tg + MO1-inpp5e
|
control
|
Fig. 4
from Xu et al., 2017
|